Depressive disorder
|
0.340 |
GeneticVariation
|
disease |
BEFREE |
In this study, we evaluated whether genetic variation in the CHRM2 gene is also a risk factor for the correlated clinical characteristics of alcoholism and depression.
|
15229186 |
2004 |
Depressive disorder
|
0.340 |
GeneticVariation
|
disease |
BEFREE |
Genetic variation in the cholinergic muscarinic-2 (M(2)) receptor gene (CHRM2) has been associated with the risk for developing depression.
|
20351719 |
2011 |
Depressive disorder
|
0.340 |
Biomarker
|
disease |
PSYGENET |
Our data fail to support association with the CHRM2 polymorphisms previously implicated in the genetic aetiology of depression.
|
19181679 |
2009 |
Depressive disorder
|
0.340 |
Biomarker
|
disease |
PSYGENET |
Genetic variation in the cholinergic muscarinic-2 (M(2)) receptor gene (CHRM2) has been associated with the risk for developing depression.
|
20351719 |
2011 |
Depressive disorder
|
0.340 |
GeneticVariation
|
disease |
BEFREE |
Our data fail to support association with the CHRM2 polymorphisms previously implicated in the genetic aetiology of depression.
|
19181679 |
2009 |
Depressive disorder
|
0.340 |
Biomarker
|
disease |
PSYGENET |
These results are consistent with a gender-specific role of the CHRM2 gene in depression in women.
|
12116189 |
2002 |
Depressive disorder
|
0.340 |
Biomarker
|
disease |
BEFREE |
These results are consistent with a gender-specific role of the CHRM2 gene in depression in women.
|
12116189 |
2002 |
Schizophrenia
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
The authors tried to verify this hypothesis by testing for possible associations between two muscarinic receptor genes (CHRM1 and CHRM2) polymorphisms and TD in patients with schizophrenia.
|
30623717 |
2019 |
Schizophrenia
|
0.320 |
Biomarker
|
disease |
PSYGENET |
These deficits were related to SNPs from 16 genes, several previously associated with schizophrenia risk and/or involved in normal central nervous system development, including AKT, PI3K, SLC6A4, DRD2, CHRM2, and ADORA2A.
|
20691427 |
2010 |
Schizophrenia
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
CHRM2 polymorphisms may play an important role in ANS activity in patients with schizophrenia.
|
27923235 |
2016 |
Substance Dependence
|
0.320 |
Biomarker
|
disease |
CTD_human |
Altered neural cholinergic receptor systems in cocaine-addicted subjects.
|
20393457 |
2010 |
Substance Dependence
|
0.320 |
Biomarker
|
disease |
BEFREE |
We assessed dimensions of the five-factor model of personality, and genotyped six CHRM2 markers and 38 unlinked ancestry-informative markers in 239 subjects with SD [173 European-Americans (EAs) and 66 African-Americans (AAs)] and 275 healthy subjects (237 EAs and 38 AAs).
|
17468496 |
2007 |
Substance Dependence
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
This group also showed a greater prevalence of a CHRM2 genotype previously associated with substance dependence and Major Depressive Disorder as well as a modest elevation on a non-planning impulsiveness scale.
|
24530440 |
2014 |
Bipolar Disorder
|
0.310 |
Biomarker
|
disease |
PSYGENET |
These data represent novel preliminary evidence that reduced M(2)-receptor V(T) in BD is associated with genetic variation within CHRM2.
|
20351719 |
2011 |
Bipolar Disorder
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
These data represent novel preliminary evidence that reduced M(2)-receptor V(T) in BD is associated with genetic variation within CHRM2.
|
20351719 |
2011 |
Neurogenic Urinary Bladder
|
0.310 |
Biomarker
|
disease |
LHGDN |
The M2 muscarinic receptor mediates in vitro bladder contractions from patients with neurogenic bladder dysfunction.
|
14751843 |
2004 |
Neurogenic Urinary Bladder
|
0.310 |
Therapeutic
|
disease |
CTD_human |
The M2-muscarinic receptor inhibits the development of streptozotocin-induced neuropathy in mouse urinary bladder.
|
20624991 |
2010 |
Epilepsy
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
Genetic polymorphisms of CYP3A5, CHRM2, and ZNF498 and their association with epilepsy susceptibility: a pharmacogenetic and case-control study.
|
31564953 |
2019 |
Epilepsy
|
0.310 |
Biomarker
|
disease |
CTD_human |
Acetylcholine-induced seizure-like activity and modified cholinergic gene expression in chronically epileptic rats.
|
18333967 |
2008 |
Alloxan Diabetes
|
0.300 |
Biomarker
|
disease |
CTD_human |
Increase of cardiac M2-muscarinic receptor gene expression in type-1 but not in type-2 diabetic rats.
|
18603373 |
2008 |
Diabetes Mellitus, Experimental
|
0.300 |
Biomarker
|
disease |
CTD_human |
Increase of cardiac M2-muscarinic receptor gene expression in type-1 but not in type-2 diabetic rats.
|
18603373 |
2008 |
Diabetes Mellitus, Insulin-Dependent
|
0.300 |
Biomarker
|
disease |
CTD_human |
Increase of cardiac M2-muscarinic receptor gene expression in type-1 but not in type-2 diabetic rats.
|
18603373 |
2008 |
Organic Mental Disorders, Substance-Induced
|
0.300 |
Biomarker
|
disease |
CTD_human |
Altered neural cholinergic receptor systems in cocaine-addicted subjects.
|
20393457 |
2010 |
Streptozotocin Diabetes
|
0.300 |
Biomarker
|
disease |
CTD_human |
Increase of cardiac M2-muscarinic receptor gene expression in type-1 but not in type-2 diabetic rats.
|
18603373 |
2008 |
Epilepsy, Cryptogenic
|
0.300 |
Biomarker
|
disease |
CTD_human |
Acetylcholine-induced seizure-like activity and modified cholinergic gene expression in chronically epileptic rats.
|
18333967 |
2008 |